Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
Isis Pharmaceuticals Adds More Deals to Partnership Portfolio 12/12/12 San Diego
Tantalizing Hints of Progress Against ALS for Cytokinetics, Others 11/14/12 San Francisco
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
IPOs, Biogen, Northeastern, & More From the Boston Life Sciences Roundup 08/17/12 Boston
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Biogen Idec, Regulus Cut Deal to Monitor Multiple Sclerosis 08/15/12 San Diego
Biogen Idec, Isis Forge 2nd Alliance This Year for Rare Disease 06/29/12 Boston
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig’s Disease 04/25/12 San Francisco
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Boston and Cambridge Renew Rivalry in Startup Real Estate 04/13/12 Boston
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals 04/05/12 San Diego
Xconomy Boston’s Top 20 Stories of Q1: Editor’s Picks 04/02/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
New England’s Emerging Biotech Stars: The Agenda 03/08/12 Boston
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
Energy Points, Biogen, Navinet, & More Boston Dealmakers 02/15/12 Boston
Biogen Idec Lets Stromedix Do The Hard Part 02/14/12 Boston
Biogen Buys Stromedix for $75M, Regaining Fibrosis Drug 02/14/12 Boston
Page 3 of 17 « previous page · next page »